Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Peripheral × fludarabine × Clear all

NCT04083495 2025-09-22

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Phase 2 Recruiting

Lymphoma, Lymphoma, T-Cell, Peripheral

NCT05883449 2025-08-20

LuminICE-203

Phase 2 Terminated

25 enrolled 21 charts

Hodgkin Disease, Recurrence, Lymphoma, T-Cell, Peripheral

NCT06468267 2024-08-01

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT00840385 2010-09-15

FAD

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral